Dr. May Dongmei Wang is Wallace H. Coulter Distinguished Faculty Fellow and full professor in BME and ECE at Georgia Institute of Technology (GT) and Emory University (EU). Her research is in Biomedical Big Data and AI with application of Intelligent Reality for predictive, personalized, and precision health (pHealth). She published 260+ peer-reviewed articles in referred journals and conference proceedings with 13,400+ GS citations, and delivered 250+ invited and keynote lectures.
Dr. Wang is the Director of Biomedical Big Data Initiative, a Georgia Distinguished Cancer Scholar, a Petit Institute Faculty Fellow, a Kavli Fellow, a Fellow of AIMBE, IAMBE, and IEEE, and a member of Board of Directors in American Board of AI in Medicine (ABAIM). As a non-clinician, Dr. Wang has help train clinicians for AI in ABAIM. Currently, besides being BoD in ABAIM, Dr. Wang is the Senior Editor for IEEE Journal of Biomedical & Health Informatics (J-BHI), an Associate Editor for IEEE Transactions for BME, and IEEE Reviews for BME, a regular panelist for NIH CDMA study section, NSF Smart and Connect Health, Brain Canada and multiple European countries. She co-organizes IEEE Healthcare Summit on Integrating BHI and AI to Combat Pandemics, and IEEE-JBHI Special Issue on AI-driven Informatics, Sensing, Imaging and Big Data Analytics for Fighting the COVID-19 Pandemic.
Dr. Wang helps grow the large BHI communities for 12 years. In 2022, she serves in IEEE Future Directions Committee. In 2021, she was selected into GT Provost’s Emerging Leaders Program, and elected to International Academy of Medical and Biological Engineering (IAMBE) Executive Committee besides serving as Chair for IEEE BHI-TC and ACM SIGBio. During 2018-2020, she was Carol Ann and David Flanagan Distinguished Faculty Fellow at GT. During 2023-2024 and 2017-2019, she was elected IEEE-EMBS VP twice. During 2015-2017, she was GT Biomedical Informatics Program Co-Director in Atlanta Clinical and Translational Science Institute (ACTSI), and 2016 IEEE-EMBS Annual Conference Chair. During 2014-2015, she was IEEE-EMBS Distinguished Lecturer, and an Emerging Area Editor for Proceedings of National Academy of Sciences. Before 2016, Dr. Wang was Director of Bioinformatics and Biocomputing Core in NIH/NCI-sponsored U54 Center for Cancer Nanotechnology Excellence, and Co-Director of Georgia-Tech Center of Bio-Imaging Mass Spectrometry for over 10 years. Dr. Wang received BEng from Tsinghua University China, and MS with PhD degrees from GT. She is a recipient of GT Outstanding Faculty Mentor Award and EU MilliPub Award (for a high-impact paper that is cited over 1,000 times). Her research has been supported by NIH, NSF, CDC, Georgia Research Alliance, Georgia Cancer Coalition, Shriners’ Hospitals for Children, Children’s Health Care of Atlanta, Enduring Heart Foundation, Coulter Foundation, Microsoft Research, HP, UCB, and Amazon.